US PTAB Patent Cases
8,722 decisions indexed
Page 197 of 291 · 8,722 total
Hecht, Thomas v.Carver Edison, Inc.
Petitioner Thomas Hecht filed an IPR challenging 18 claims of U.S. Patent No. 10,445,833, arguing the methods for maximizing ESPP shares are obvious over prior art combining financial and computer technology.
Hecht, Thomas v.Carver Edison, Inc.
Thomas Hecht filed an IPR challenging 18 claims of U.S. Patent No. 10,445,833. The petition asserts that the patent is obvious over prior art (Hecht's own disclosure and Sullivan) when combined with known computer technology like volatility modules and containerization.
Imperative Care, Inc. v.INARI MEDICAL, INC.
Imperative Care, Inc. successfully challenged nine claims of INARI MEDICAL's hemostasis valve patent (11697011) at the PTAB. The Board found sufficient evidence for Petitioner’s anticipation challenge against Claim 1 after adopting a broad interpretation of the term 'filament.'
Imperative Care, Inc. v.INARI MEDICAL, INC.
The Board found that the claims were unpatentable under obviousness (Grounds 3 and 4), specifically over a combination of Schaffer's valve with Hartley's string or Eller's wire. The decision hinged on finding that a POSA would have had reason to make this substitution, leading to predictable results in hemostatic device design.
Recycled Plastics Industries, LLC et al. v.Tangent Technologies LLC et al.
Recycled Plastics Industries and Tangent Technologies settled their dispute over U.S. Patent 10,981,350 B1, prompting the PTAB to terminate the IPR before it was instituted.
Recycled Plastics Industries, LLC et al. v.Tangent Technologies LLC et al.
Recycled Plastics Industries and Tangent Technologies filed a joint motion to terminate IPR No. 2024‑00898, seeking confidential treatment of their settlement agreement under 35 U.S.C. §317. The parties argue the settlement resolves all issues concerning patent 10,981,350.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom filed a joint request with the PTAB to keep their settlement agreement confidential, invoking statutory provisions for business‑confidential treatment.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom have entered a confidential settlement and jointly moved to terminate IPR2024-00861 covering DexCom’s glucose‑monitor patent. The Board has not yet decided the merits, and the parties cite statutory authority for termination.
Recycled Plastics Industries, LLC et al. v.Tangent Technologies LLC et al.
Recycled Plastics Industries and Tangent Technologies filed a joint motion to terminate IPR2024-00898 after reaching a settlement that resolves all disputes over the ’350 patent covering wood‑plastic composite technology.
Recycled Plastics Industries, LLC et al. v.Tangent Technologies LLC et al.
Recycled Plastics Industries and Tangent Technologies jointly filed a motion to terminate IPR2024-00898 concerning U.S. Patent 10,981,350. The motion reflects a settlement between the parties, ending the proceeding.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their IPR dispute over U.S. Patent 9,801,541, filing a joint motion that led the PTAB to terminate the proceeding and keep the settlement agreement confidential.
Recycled Plastics Industries, LLC et al. v.Tangent Technologies LLC et al.
Recycled Plastics Industries and Tangent Technologies have filed a joint motion to terminate IPR2024-00898 concerning patent 10,981,350. The parties seek dismissal of the proceeding.
Recycled Plastics Industries, LLC et al. v.Tangent Technologies LLC et al.
A petition challenges a polymer board patent by asserting that the claimed simulated wood-grained structure is obvious. The petitioner relies on combining multiple prior art references, including StaMixCo and Zumbrunnen, to demonstrate lack of inventive step.
Voltage, LLC et al. v.Shoals Technologies Group, LLC
Voltage, LLC challenges Shoals Technologies Group's photovoltaic connector patents under 35 U.S.C. § 103. The petitioner argues the claims are obvious by combining conventional elements found across several prior art references related to solar power installations.
Voltage, LLC et al. v.Shoals Technologies Group, LLC
Voltage, LLC has filed an opening petition challenging Shoals Technologies Group's solar power patents on grounds of obviousness under 35 U.S.C. § 103. The petitioner asserts that the claimed lead assembly configurations are merely conventional combinations of known wiring and molding techniques found in multiple prior art references.
Ericsson Inc. et al. v.XR COMMUNICATIONS LLC
Ericsson Inc. et al. filed an Initial Petition for Inter Partes Review (IPR) against XR Communications LLC's patent related to wireless communications. The petition challenges key claims under 35 U.S.C. § 103, asserting that the technology is obvious over prior art references Trigui and Rudrapatna. The grounds focus on the predictability of adopting a 'cross' connect approach for MIMO transceivers.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care Inc. filed an IPR petition challenging DexCom's remote monitoring patents, arguing that the claims are obvious. The petitioner asserts that various combinations of prior art references render the claimed methods and systems unpatentable.
Voltage, LLC et al. v.Shoals Technologies Group, LLC
Voltage, LLC failed its IPR challenge against Shoals Technologies Group regarding photovoltaic connectors. The PTAB denied the petition, finding that the combination of prior art references lacked sufficient motivation to render the claims obvious under 35 U.S.C. § 103.
Voltage, LLC et al. v.Shoals Technologies Group, LLC
Voltage, LLC's IPR petition against Shoals Technologies Group, LLC was denied by the PTAB, finding that the petitioner failed to demonstrate a reasonable likelihood of prevailing on any claim. The dispute centered on obviousness grounds (35 U.S.C. § 103) regarding solar power interconnection systems.
Ericsson Inc. et al. v.XR COMMUNICATIONS LLC
The PTAB instituted trial in an IPR proceeding concerning MIMO/Beamforming antenna technology. The Board found sufficient evidence to suggest that several challenged claims are unpatentable over the prior art, specifically Trigui and Rudrapatna. This decision moves the dispute forward toward a full evidentiary hearing on obviousness grounds.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care successfully petitioned to institute IPR proceedings against DexCom regarding claims related to remote patient monitoring and glucose management. The PTAB found sufficient evidence that the petitioner met its burden of demonstrating a reasonable likelihood of prevailing on multiple grounds (102 and 103).
Ericsson Inc. et al. v.XR COMMUNICATIONS LLC
The PTAB issued a Final Written Decision finding all 17 challenged claims unpatentable under 35 U.S.C. § 103(a). The Board determined that the prior art reference Trigui disclosed sufficient elements, rendering the claimed MIMO/Beamforming technology obvious to a person having ordinary skill in the art (PHOSITA).
Hulu LLC et al. v.--
Hulu and Capital One filed an unopposed motion to keep their settlement agreement with Implicit confidential and to terminate the IPR. The Board is asked to treat the agreement as business confidential information under 35 U.S.C. §317(b).
Hulu LLC et al. v.--
Hulu and Capital One filed an unopposed motion to terminate IPR2024-00787 after settling their dispute with patent owner Implicit, LLC. The Board was asked to end the proceeding, which had not yet been instituted.
Hulu LLC et al. v.--
Hulu and Capital One filed an unopposed motion to terminate IPR2024‑00787 and to keep the settlement agreement with Implicit, LLC confidential under statutory provisions.
Hulu LLC et al. v.--
Hulu and Capital One settled their IPR dispute with patent owner Implicit, leading the PTAB to terminate the proceeding before trial. The Board granted motions to keep the settlement agreements confidential.
Amazon.com, Inc. et al. v.Nokia Technologies Oy
Amazon and Nokia filed a joint motion to terminate IPR2024‑00604 and submitted a settlement agreement. The Board granted the termination and partially granted confidentiality of the settlement documents.
Amazon.com, Inc. et al. v.Nokia Technologies Oy
Amazon and Nokia settled their dispute over a video‑device patent and jointly moved to terminate the inter partes review, ending the proceeding.
Amazon.com, Inc. et al. v.Nokia Technologies Oy
Amazon and Nokia jointly filed a settlement and motion to terminate IPR2024-00605 covering Nokia’s patent 10,536,714. The Board granted termination and partially approved confidentiality of the settlement documents.
Amazon.com, Inc. et al. v.Nokia Technologies Oy
Amazon and Nokia have settled their IPR dispute over U.S. Patent 10,536,714 and jointly moved to terminate the proceeding, requesting the settlement documents be kept confidential.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.